2100 Sarno Rd. Melbourne, FL 32935
+1 321-508-3500
Manon Fiorot Suspended Three Months After Ostarine Finding - Manon Fiorot suspension UFC News News
Manon Fiorot during a February 2023 interview. The photograph predates the November 2026 anti-doping decision.

Image credit: Lucie Bertaud / Wikimedia Commons · CC BY 3.0

Manon Fiorot has accepted a three-month suspension under the UFC Anti-Doping Policy after an in-competition sample detected a low level of ostarine.

Combat Sports Anti-Doping announced the sanction Thursday. The sample was collected September 12 at Noche UFC, where Fiorot lost a unanimous decision to Alexa Grasso. Her period of ineligibility began October 19, when she was notified of the finding, and ends January 19, 2027.

The headline needs the rest of the story. CSAD said its investigation traced the result to two contaminated supplements supplied by a nutritionist during fight week. The agency found no evidence of intentional use and said the amount involved offered no significant performance advantage.

What the investigation found

Fiorot told investigators that the nutritionist had added several supplements to her routine during fight week. She said she stopped taking them after the event. The nutritionist had kept portions of the products, allowing the Sports Medicine and Research Testing Laboratory to examine them.

Two supplements tested positive for ostarine. One contained about 2.8 micrograms per capsule and the other about 9 micrograms. CSAD compared those amounts with the 1,000-microgram doses used in clinical research. The products had not been independently tested and certified as free of banned substances.

Before she learned of the positive result, Fiorot provided another sample on October 19. That test was negative. Combined with the supplement testing and her cooperation, the follow-up result supported her account that the exposure was limited to fight week.

CSAD said the evidence was "consistent with inadvertent exposure resulting from low-level ostarine contamination of the supplements, rather than intentional use." The agency also concluded that the amount detected did not give Fiorot a meaningful competitive benefit.

Why the suspension is three months

Ostarine is an anabolic agent prohibited at all times under the UFC policy. Fiorot still accepted an anti-doping violation, even though CSAD found that the exposure was accidental.

The policy allows CSAD to reduce or suspend a period of ineligibility when an athlete gives full and complete cooperation. The agency cited Fiorot's cooperation, the negative follow-up test, the laboratory results from the supplements and the absence of a significant performance advantage when setting the sanction at three months.

The Arizona State Boxing and Mixed Martial Arts Commission also had jurisdiction because Noche UFC took place in Glendale. According to the UFC statement, the commission will recognize CSAD's suspension and will not add a separate penalty.

What it means for Fiorot

The suspension is unlikely to keep Fiorot out for long. More than a month of it had already elapsed when the decision became public, and she will be eligible to compete again on January 19. No return fight has been announced.

Fiorot remains one of the most established fighters in the UFC women's flyweight division. She challenged Valentina Shevchenko for the title in 2025, then beat Jasmine Jasudavicius before the loss to Grasso. The Grasso result remains on her record; neither CSAD nor the Arizona commission announced a change to the bout.

There is an important distinction here. Fiorot did not avoid a violation, but the investigation did not accuse her of deliberately taking ostarine. CSAD's findings put the responsibility on contaminated, uncertified supplements and documented why the penalty was limited to three months.

The supplement warning

The case is another blunt reminder that a label is not a laboratory report. The UFC says athletes are regularly told to use products that have been independently tested and certified. Neither supplement identified in Fiorot's case had that protection.

Fiorot's nutritionist retained enough of the products to make direct testing possible. Without those samples, connecting a positive test to contamination would have been far more difficult. This time there was a clear paper trail: the original sample, a negative follow-up, the actual capsules and laboratory measurements from both products.

Sources

Found an error? Send a correction and include this article’s URL.

Share this article:

Related Stories